Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0036 | 0.0014 | 0.0374 |
Loa Loa (eye worm) | D-ets-4 DNA binding domain-containing protein | 0.0072 | 0.0087 | 0.228 |
Brugia malayi | TAR-binding protein | 0.007 | 0.0083 | 0.0114 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0083 | 0.2173 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Schistosoma mansoni | ets-related | 0.022 | 0.0381 | 1 |
Mycobacterium ulcerans | DNA polymerase I | 0.0229 | 0.04 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0049 | 0.004 | 0.1052 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Onchocerca volvulus | 0.0036 | 0.0014 | 0.0014 | |
Trypanosoma cruzi | mitochondrial structure specific endonuclease I (SSE-1), putative | 0.0163 | 0.0267 | 0.0946 |
Echinococcus granulosus | twinkle protein mitochondrial | 0.0049 | 0.004 | 0.1263 |
Echinococcus multilocularis | geminin | 0.0188 | 0.0318 | 1 |
Mycobacterium leprae | PROBABLE DNA POLYMERASE I POLA | 0.0229 | 0.04 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase I protein A, putative | 0.0066 | 0.0075 | 0.0226 |
Plasmodium falciparum | 5'-3' exonuclease, N-terminal resolvase-like domain, putative | 0.0163 | 0.0267 | 0.0737 |
Trypanosoma brucei | mitochondrial DNA polymerase I protein A, putative | 0.0066 | 0.0075 | 0.0226 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0036 | 0.0014 | 0.0448 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.1374 | 0.269 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.15 |
Loa Loa (eye worm) | TAR-binding protein | 0.007 | 0.0083 | 0.2173 |
Onchocerca volvulus | Huntingtin homolog | 0.0136 | 0.0214 | 0.0214 |
Brugia malayi | hypothetical protein | 0.0136 | 0.0214 | 0.0295 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.0214 | 0.5613 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.004 | 0.1261 |
Mycobacterium tuberculosis | Probable DNA polymerase I PolA | 0.0229 | 0.04 | 0.9954 |
Leishmania major | mitochondrial DNA polymerase I protein A, putative | 0.0066 | 0.0075 | 0.0226 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Schistosoma mansoni | hypothetical protein | 0.0038 | 0.0019 | 0.0505 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0049 | 0.004 | 0.1261 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.0049 | 0.0067 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0075 | 0.1962 |
Echinococcus multilocularis | tar DNA binding protein | 0.007 | 0.0083 | 0.2604 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.004 | 0.1054 |
Trichomonas vaginalis | DNA polymerase I, putative | 0.0066 | 0.0075 | 1 |
Brugia malayi | Ets-domain containing protein | 0.0072 | 0.0087 | 0.012 |
Onchocerca volvulus | 0.0036 | 0.0014 | 0.0014 | |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.0014 | 0.0374 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0015 | 0.0021 |
Brugia malayi | DNA polymerase I family protein | 0.0066 | 0.0075 | 0.0103 |
Leishmania major | mitochondrial structure specific endonuclease I (SSE-1), putative | 0.0163 | 0.0267 | 0.0946 |
Mycobacterium ulcerans | 5'-3' exonuclease | 0.0163 | 0.0267 | 0.6565 |
Echinococcus granulosus | tar DNA binding protein | 0.007 | 0.0083 | 0.2604 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0015 | 0.0398 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.0049 | 0.0067 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0036 | 0.0014 | 0.002 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 0.0318 | 0.8343 |
Onchocerca volvulus | Huntingtin homolog | 0.0136 | 0.0214 | 0.0214 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0038 | 0.0019 | 0.0605 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.1494 |
Chlamydia trachomatis | DNA polymerase I | 0.0229 | 0.04 | 0.5 |
Loa Loa (eye worm) | twinkle helicase | 0.0049 | 0.004 | 0.1054 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.1891 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0083 | 0.2173 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.004 | 0.1052 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.004 | 0.1261 |
Schistosoma mansoni | DNA polymerase I | 0.0066 | 0.0075 | 0.1962 |
Trypanosoma cruzi | mitochondrial DNA polymerase I protein A, putative | 0.0066 | 0.0075 | 0.0226 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.15 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0038 | 0.0019 | 0.0605 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0049 | 0.004 | 0.0055 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0065 | 0.0072 | 0.0216 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.15 |
Echinococcus multilocularis | GA binding protein alpha chain | 0.0072 | 0.0087 | 0.2733 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0036 | 0.0014 | 0.0374 |
Brugia malayi | RNA recognition motif domain containing protein | 0.007 | 0.0083 | 0.0114 |
Wolbachia endosymbiont of Brugia malayi | DNA polymerase I | 0.0229 | 0.04 | 0.5 |
Schistosoma mansoni | gabp alpha | 0.0072 | 0.0087 | 0.228 |
Toxoplasma gondii | DNA polymerase I domain-containing protein | 0.0066 | 0.0075 | 0.0226 |
Loa Loa (eye worm) | fli-1 protein | 0.022 | 0.0381 | 1 |
Brugia malayi | Ets-domain containing protein | 0.0072 | 0.0087 | 0.012 |
Schistosoma mansoni | hypothetical protein | 0.0049 | 0.004 | 0.1054 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0065 | 0.0072 | 0.2267 |
Onchocerca volvulus | 0.0036 | 0.0014 | 0.0014 | |
Loa Loa (eye worm) | RNA binding protein | 0.007 | 0.0083 | 0.2173 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0036 | 0.0014 | 0.0448 |
Plasmodium vivax | plastid replication-repair enzyme, putative | 0.0066 | 0.0075 | 0.0226 |
Brugia malayi | Fli-1 protein | 0.022 | 0.0381 | 0.0526 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0015 | 0.0398 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.007 | 0.0083 | 0.2173 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0066 | 0.1731 |
Echinococcus multilocularis | twinkle protein, mitochondrial | 0.0049 | 0.004 | 0.1263 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.0216 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0083 | 0.2173 |
Onchocerca volvulus | Twinkle protein, mitochondrial homolog | 0.0049 | 0.004 | 0.004 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0049 | 0.004 | 0.1261 |
Mycobacterium tuberculosis | Probable 5'-3' exonuclease | 0.0163 | 0.0267 | 0.6535 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.0049 | 0.1282 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0083 | 0.2173 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0014 | 0.0374 |
Toxoplasma gondii | 5'-3' exonuclease, N-terminal resolvase family domain-containing protein | 0.008 | 0.0102 | 0.0327 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1374 | 0.269 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0065 | 0.0072 | 0.1891 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0019 | 0.0027 |
Brugia malayi | RNA binding protein | 0.007 | 0.0083 | 0.0114 |
Trypanosoma brucei | mitochondrial structure specific endonuclease I (SSE-1), putative | 0.0163 | 0.0267 | 0.0946 |
Toxoplasma gondii | helicase, putative | 0.0066 | 0.0075 | 0.0226 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.0014 | 0.002 |
Echinococcus granulosus | geminin | 0.0188 | 0.0318 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0136 | 0.0214 | 0.5613 |
Treponema pallidum | DNA polymerase I (polA) | 0.0229 | 0.04 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0036 | 0.0014 | 0.002 |
Giardia lamblia | Telomerase catalytic subunit | 0.1374 | 0.269 | 0.5 |
Trypanosoma cruzi | mitochondrial structure specific endonuclease I (SSE-1), putative | 0.0163 | 0.0267 | 0.0946 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.1374 | 0.269 | 1 |
Entamoeba histolytica | DNA-directed DNA polymerase, putative | 0.0066 | 0.0075 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0065 | 0.0072 | 0.2267 |
Brugia malayi | Telomerase reverse transcriptase | 0.3658 | 0.7253 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0049 | 0.1282 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.1374 | 0.269 | 1 |
Leishmania major | telomerase reverse transcriptase, putative | 0.1374 | 0.269 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.004 | 0.1052 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.1374 | 0.269 | 1 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.1374 | 0.269 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0188 | 0.0318 | 0.8343 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.023 | 0.0402 | 1 |
Brugia malayi | beta-lactamase | 0.0036 | 0.0014 | 0.002 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0038 | 0.0019 | 0.0505 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0049 | 0.004 | 0.1052 |
Plasmodium vivax | 5'-3' exonuclease, N-terminal resolvase-like domain, putative | 0.0163 | 0.0267 | 0.0946 |
Schistosoma mansoni | tar DNA-binding protein | 0.007 | 0.0083 | 0.2173 |
Echinococcus granulosus | GA binding protein alpha chain | 0.0072 | 0.0087 | 0.2733 |
Trypanosoma brucei | mitochondrial DNA polymerase I protein A, putative | 0.0066 | 0.0075 | 0.0226 |
Loa Loa (eye worm) | beta-lactamase | 0.0036 | 0.0014 | 0.0374 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Relative SEAP activity (functional) | = 107 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 107 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 111 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 260.0 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 111 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 260.0 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 114 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 114 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 118 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 26 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 118 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in non-small cell lung cancer H1299 cell at 26 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 119 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in immortalized hTERT-BJI at 26 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 119 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in immortalized hTERT-BJI at 26 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 134 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in immortalized hTERT-BJI at 260.0 microM concentration | ChEMBL. | 12852760 |
Relative SEAP activity (functional) | = 134 % | Compound was tested for human telomerase reverse transcriptase-SEAP (hTERT-SEAP) activity in immortalized hTERT-BJI at 260.0 microM concentration | ChEMBL. | 12852760 |
Relative viability (functional) | = 85 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in immortalized hTERT-BJI at 260.0 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 85 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in immortalized hTERT-BJI at 260.0 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 87 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 260.0 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 87 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 260.0 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 106 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 26 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 106 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in immortalized hTERT-BJI at 26 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 106 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 26 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 106 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in immortalized hTERT-BJI at 26 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 107 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 107 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 109 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Relative viability (functional) | = 109 % | hTERT-SEAP (Human telomerase reverse transcriptase-SEAP) activity in non-small cell lung cancer H1299 cell at 2.6 microM concentration and level of cell viability determined in MTT assay | ChEMBL. | 12852760 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.